Damaged articular cartilage does not heal by itself and could deteriorate to severe cartilage defects. To truly repair articular cartilage you need chondrocytes, your body’s own cartilage cells.
Over 1.2 million articular cartilage injuries occur annually in the U.S. and Europe. These cartilage injuries can degenerate into more severe cartilage defects. Patients suffering from knee pain and functional impairment may result in a decrease in quality of life and could eventually require a total knee replacement – if untreated.
Clinical outcomes of the first 40 patients treated with CartiONE within the INSTRUCT trial were published in The American Journal of Sports Medicine in May 2020.
Every year there are more 630,000 total knee replacements performed in the US and Europe. Our goals are to delay or prevent total knee replacement by treating Cartilage lesions.
With CartiONE, we have developed a unique joint preservation solution for orthopaedic/sports medicine surgeons that encourage a patient’s own natural healing process. CartiONE offers an innovative regenerative medicine approach to soft tissue defects in joints for patients suffering from injury or cartilage degeneration.
